User menu

A multicenter phase II trial of gefitinib 500 mg/day in 193 patients with advanced epidermal growth factor receptor-positive solid tumors who had failed previous chemotherapy: Interim data

Bibliographic reference Vergote, IB ; Humblet, Yves ; Van Cutsem, E. ; Van Belle, S. ; Kerger, Joseph ; et. al. A multicenter phase II trial of gefitinib 500 mg/day in 193 patients with advanced epidermal growth factor receptor-positive solid tumors who had failed previous chemotherapy: Interim data.41st Annual Meeting of the American-Society-of-Clinical-Oncology (Orlando (Fl), May 13-17, 2005). In: Journal of Clinical Oncology, Vol. 23, no. 16, p. 231S-231S (2005)
Permanent URL http://hdl.handle.net/2078.1/60903